Back
America Movil SAB de CV Vs. Nektar Therapeutics Industry Stock Comparison
Sell
50
AMX
America Movil SAB de CV
Last Price:
$21.33
Seasonality Move:
2.01%
Sell
34
NKTR
Nektar Therapeutics
Last Price:
$54.70
Seasonality Move:
11.58%
Sell
50
America Movil SAB de CV (AMX)
is a Sell
Is America Movil SAB de CV a Buy, Sell or Hold?
-
The current America Movil SAB de CV [AMX] share price is $21.33. The Score for AMX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
AMX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AMX Stock Price Chart
What is America Movil SAB de CV's stock price today?
-
The America Movil SAB de CV share price today is $21.33Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMX is experiencing buying pressure, which is a positive indicator for future bullish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $54.70Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.
AMX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.36 | Sell |
| Relative Strength Index (14 RSI): | 35.18 | Sell |
| Chaikin Money Flow: | 714415 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.76 - 23.36) | Sell |
| Bollinger Bands (100): | (19.33 - 22.59) | Buy |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.71 | Sell |
| Relative Strength Index (14 RSI): | 45.77 | Sell |
| Chaikin Money Flow: | 141668 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.71 - 61.07) | Sell |
| Bollinger Bands (100): | (32.74 - 62.56) | Buy |
AMX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.47 | Sell |
| 20-day SMA: | 22.38 | Sell |
| 50-day SMA: | 22.34 | Sell |
| 200-day SMA: | 18.62 | Buy |
| 8-day EMA: | 21.58 | Sell |
| 20-day EMA: | 22.07 | Sell |
| 50-day EMA: | 21.98 | Sell |
| 200-day EMA: | 19.52 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.42 | Sell |
| 20-day SMA: | 58.12 | Sell |
| 50-day SMA: | 58.41 | Sell |
| 200-day SMA: | 30.65 | Buy |
| 8-day EMA: | 56.16 | Sell |
| 20-day EMA: | 57.43 | Sell |
| 50-day EMA: | 55.78 | Sell |
| 200-day EMA: | 37.86 | Buy |
America Movil SAB de CV Earnings Growth & AMX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.85 per share, and an increase next year of $0.19 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.
America Movil SAB de CV Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||